The abstract is read at the publisher; the summary is JClub's.
Circulating fatty acid synthase (cFAS) associates with lipoproteins and promotes macrophage foam cell formation independently of low-density lipoprotein cholesterol concentration.
- Why it matters: Atherosclerosis risk is not fully explained by LDL-C, and atherogenic mechanisms linked to lipoprotein-associated enzymes could improve diagnosis and targeting.
- What they did: The review synthesizes evidence that cFAS is primarily hepatic and released with enhanced de novo lipogenesis and insulin resistance, with adipose extrusion as a possible contributor.
- The result: cFAS is established as a diagnostic biomarker for peripheral arterial disease, with higher concentrations in affected individuals and potential linkage to more severe disease.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.